The Regenerative Medicine Advanced Therapies designation of RP-A501, which happens to be an adeno-associated virus-based gene therapy when it comes...
Read moreThe US and Switzerland have agreed to a Mutual Recognition Agreement (MRA) on pharmaceutical Good Manufacturing Practices (GMP). The US...
Read moreThe biotechnology sector had a decline in 2022 that went beyond just falling stock prices. Additionally, only 37 new drugs...
Read moreAtezolizumab (Tecentriq), a therapy for advanced alveolar soft tissue sarcoma (ASPS), has received FDA approval for the first time for...
Read moreThe FDA recorded only 37 new drug approvals in 2022, down from an annual average of 51 since 2017. After...
Read moreThe generic version of the COVID-19 oral antiviral therapy candidate nirmatrelvir has been approved by the World Health Organization Prequalification...
Read moreThe first gene therapy for non-muscle invasive bladder cancer (NMIBC) in individuals with high-risk carcinoma in situ (CIS) with or...
Read moreThe agency that suggests which medications should be allowed in Europe has backed five new ones, including a gene therapy...
Read moreWhat changes are in store for the European Human Medicines Directive and Regulation when it is amended at the end...
Read moreThere is a new medicine that has surpassed Bluebird Bio as the costliest in the world. Hemgenix, a haemophilia B...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.